We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Unique Molecular Features in High-Risk Histology Endometrial Cancers.
- Authors
Pandita, Pooja; Wang, Xiyin; Jones, Devin E.; Collins, Kaitlyn; Hawkins, Shannon M.
- Abstract
Endometrial cancer is the most common gynecologic malignancy in the United States and the sixth most common cancer in women worldwide. Fortunately, most women who develop endometrial cancer have low-grade early-stage endometrioid carcinomas, and simple hysterectomy is curative. Unfortunately, 15% of women with endometrial cancer will develop high-risk histologic tumors including uterine carcinosarcoma or high-grade endometrioid, clear cell, or serous carcinomas. These high-risk histologic tumors account for more than 50% of deaths from this disease. In this review, we will highlight the biologic differences between low- and high-risk carcinomas with a focus on the cell of origin, early precursor lesions including atrophic and proliferative endometrium, and the potential role of stem cells. We will discuss treatment, including standard of care therapy, hormonal therapy, and precision medicine-based or targeted molecular therapies. We will also discuss the impact and need for model systems. The molecular underpinnings behind this high death to incidence ratio are important to understand and improve outcomes.
- Subjects
UNITED States; ANTINEOPLASTIC agents; HISTOLOGY; EVALUATION of medical care; MOLECULAR pathology; STEM cells; UTERINE tumors; ENDOMETRIAL tumors; INDIVIDUALIZED medicine
- Publication
Cancers, 2019, Vol 11, Issue 11, p1665
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers11111665